摘要:
The claimed invention provides a novel method of preparing 6-O-methyl erythromycin A. The process comprises the steps of reducing the 9-keto group of erythromycin A to form a 9-hydroxy erythromycin A, protecting the 9-, 2'-, and/or 4"-hydroxyl groups of erythromycin A, selectively methylating the 6-position of the 9-hydroxy erythromycin A derivative, deprotecting the hydroxyl groups and oxidizing the 9-hydroxyl to afford 6-O-methyl erythromycin A.
摘要:
The disclosed invention relates to novel 3'-N-O, 9-O-oxime protected, 6-O-alkyl erthyromycin derivatives, a process of preparing the same. The invention also relates to a process of preparing 6-O-alkyl erythromycin A by eliminating the 3'-N-oxide group and 9-O-oxime protecting groups and optionally deprotecting the hydroxy groups at the 2'- and 4"- positions under suitable reaction conditions.
摘要:
A process for clarifying an alkoxylated product mixture produced using a calcium-based catalyst wherein the product mixture is heated to a temperature of from about 80.degree. C. to about 175.degree. C. to produce a filtration feed, the filtration feed being passed through a filter medium comprising material possessing polar groups to produce a clarified filtrate, the filtration feed being passed through the filter medium within about 5 days of being prepared, the filtration feed being passed through the filter medium until the desired degree of clarification is obtained, the temperature of the clarified filtrate being less than about 30.degree. C. but above the pour point of the clarified filtrate.
摘要:
The present invention concerns the novel antiobiotic 6-O-methylerythromycin A crystal form I, a process for its preparation, pharmaceutical compositions comprising this compound and a method of use as a therapeutic agent.
摘要:
The present invention provides a process for the preparation of 6-O-methylerythromycin A Form II comprising converting erythromycin A to 6-O-methylerythromycin A and treating the 6-O-methylerythromycin A with a number of common organic solvents or mixtures of common organic solvents.
摘要:
Aminodeoxy derivatives of 3-deoxy-D-manno-2-octulosonic acid (KDO) are potent inhibitors of bacterial enzymes and a novel class of antibacterial agents.
摘要:
The present invention concerns the novel antiobiotic 6-O-methylerythromycin A form O solvate, a process for its preparation, pharmaceutical compositions comprising this compound and a method of use as a therapeutic agent.
摘要:
Novel 6-O-alkyl derivatives of erythronolide B are provided. A process for the preparation of 6-O-alkyl derivatives of erythronolide B using erythromycin B is also provided. A process for preparing 6-O-alkyl derivatives of erythromycin C using novel 6-O-alkyl derivatives of erythronolide B is further provided.
摘要:
A process for the preparation of 4"-deoxyerythromycins, having the formula: ##STR1## wherein R is H or OH, and R.sup.1 is H or loweralkyl by treatment of the 2'-O-acetyl-4"-imidazolylthionocarbonyl-erythromycin starting material with the radical initiator 4,4'-azobis-(4-cyanovaleric acid), H.sub.3 PO.sub.2 and an organic base in a water-miscible solvent and optionally eliminating the 2'-O-acetyl group. In a preferred embodiment, the water-miscible solvent is an alcohol and the deoxygenation and deacetylation is carried out in one step.
摘要翻译:一种制备4'-脱氧红霉素的方法,具有下式:其中R为H或OH,R1为H或低级烷基,通过处理2'-O-乙酰基-4“ - 咪唑硫代羰基 - 红霉素 起始材料与自由基引发剂4,4'-偶氮双(4-氰基戊酸),H 3 PO 2和有机碱在水混溶性溶剂中并任选除去2'-O-乙酰基。 在优选的实施方案中,水混溶性溶剂是醇,脱氧和脱乙酰化在一个步骤中进行。
摘要:
The present invention relates to a novel 6-O-methylerythromycin A crystal form, a process for preparing the crystal form, and methods for using the crystal form to prepare a 6-O-methylerythromycin A crystal form II.